Emerg Infect Dis. 2021 Oct;27(10):2658-61. doi: 10.3201/eid2710.211240.
Babesiosis developed in a 62-year-old immunocompetent physician, who had an uneventful recovery after receiving atovaquone and azithromycin. Three years later, babesiosis developed again, and he was again successfully given treatment. Clinical and laboratory evidence were highly supportive of reinfection. Healthcare professionals should be aware that reinfection might occur in babesiosis.
巴贝虫病发生在一位 62 岁免疫功能正常的医生身上,他在接受阿托伐醌和阿奇霉素治疗后痊愈。三年后,他再次患上巴贝虫病,并再次成功接受治疗。临床和实验室证据高度支持再次感染。医护人员应意识到巴贝虫病可能会再次感染。